Estelle Bourbon
Impact in
- Rheumatology top 5%
- Otitis Media and Relapsing Polychondritis
- IgG4-Related and Inflammatory Diseases
- Genetics top 5%
- Vascular Anomalies and Treatments
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Congenital Ear and Nasal Anomalies
Papers in
- Oncology 7
- CAR-T cell therapy research 4
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- Yvan Jamilloux (3 shared papers)Pierre Sujobert (4 shared papers)Cécile‐Audrey Durel (2 shared papers)Thomas Barba (2 shared papers)Maël Heiblig (3 shared papers)Fiorenza Barraco (1 shared paper)P. Sève (1 shared paper)Jean‐Christophe Lega (1 shared paper)
- Journals
- Hematological Oncology (2 papers)Blood (2 papers)Expert Opinion on Investigational Drugs (1 paper)British Journal of Haematology (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Estelle Bourbon
14 papers receiving 423 citations
Estelle Bourbon's Hit Papers
Peers
Comparison fields: 5 of 33
- Rheumatology 293
- Genetics 169
- Oncology 86
- Hematology 33
- Pathology and Forensic Medicine 45
Countries citing papers authored by Estelle Bourbon
This map shows the geographic impact of Estelle Bourbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estelle Bourbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estelle Bourbon more than expected).
Fields of papers citing papers by Estelle Bourbon
This network shows the impact of papers produced by Estelle Bourbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estelle Bourbon. The network helps show where Estelle Bourbon may publish in the future.
Co-authors
The 25 scholars most cited alongside Estelle Bourbon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Therapeutic options in VEXAS syndrome: insights from a retrospective series Hit paper breakdown → | 2021 | 171 |
| 2 | 2021 | 74 | |
| 3 | 2021 | 49 | |
| 4 | 2021 | 28 | |
| 5 | 2020 | 27 | |
| 6 | 2017 | 22 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 13 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2018 | 3 | |
| 12 | 2023 | 3 | |
| 13 | 2011 | 1 | |
| 14 | 2024 | 1 |
About Estelle Bourbon
Estelle Bourbon is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Molecular Biology and Rheumatology, having authored 14 papers that have together received 426 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Otitis Media and Relapsing Polychondritis (4 papers), CAR-T cell therapy research (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Vascular Anomalies and Treatments (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Rheumatology (293 citations), Genetics (169 citations), Oncology (86 citations), Hematology (33 citations) and Pathology and Forensic Medicine (45 citations). Estelle Bourbon has collaborated with scholars based in France and United States. Frequent co-authors include Yvan Jamilloux, Pierre Sujobert, Cécile‐Audrey Durel, Thomas Barba, Maël Heiblig, Fiorenza Barraco, P. Sève, Jean‐Christophe Lega, Gilles Salles and Pierre Sujobert. Their work appears in journals such as Hematological Oncology, Blood, Expert Opinion on Investigational Drugs, British Journal of Haematology and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.